Joerg M. Herrmann

Cardiology

200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 288 publications

LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis.

LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis.

Journal: Circulation research

Published: May 27, 2026

LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis.

LATS1/2-CD38 Metabolic Rewiring Links Senescence to Intraplaque Thrombosis.

Journal: Circulation research

Published: May 27, 2026

The Cardioprotective Effects of Empagliflozin with and Without ACE Inhibition in Chemotherapy-Induced Cardiotoxicity.

The Cardioprotective Effects of Empagliflozin with and Without ACE Inhibition in Chemotherapy-Induced Cardiotoxicity.

Journal: Biomedicines

Published: March 14, 2026

TNF-α Blockade Mitigates Immune Checkpoint-Related Nephritis in a Humanized Mouse Model.

TNF-α Blockade Mitigates Immune Checkpoint-Related Nephritis in a Humanized Mouse Model.

Journal: JCI insight

Published: March 05, 2026

Assessing the prognostic value of artificial intelligence for opportunistic prediction of coronary artery calcium score on routine non-gated computed tomography in patients treated with immune checkpoint inhibitors.

Assessing the prognostic value of artificial intelligence for opportunistic prediction of coronary artery calcium score on routine non-gated computed tomography in patients treated with immune checkpoint inhibitors.

Journal: Digital health

Published: February 22, 2026

Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease.

Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease.

Journal: JAMA oncology

Published: February 19, 2026

Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclines.

Glucagon-like peptide-1 receptor agonists are associated with cardiac, cancer- and mortality-related benefits in diabetic patients treated with anthracyclines.

Journal: European heart journal open

Published: February 06, 2026

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology.

The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncology.

Journal: European heart journal

Published: January 23, 2026

Medical strategies of cardiovascular protection to reduce cancer therapy-related cardiovascular toxicity: where do we stand?

Medical strategies of cardiovascular protection to reduce cancer therapy-related cardiovascular toxicity: where do we stand?

Journal: Heart (British Cardiac Society)

Published: December 14, 2025

Vascular Toxicities of Cancer Therapies: 2025 Update.

Vascular Toxicities of Cancer Therapies: 2025 Update.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 11, 2025

Diagnostic and Prognostic Value of High-Sensitivity Troponin T for Cardiovascular Outcomes in Patients Receiving Immune Checkpoint Inhibitor Therapy.

Diagnostic and Prognostic Value of High-Sensitivity Troponin T for Cardiovascular Outcomes in Patients Receiving Immune Checkpoint Inhibitor Therapy.

Journal: Journal of the American Heart Association

Published: November 26, 2025

Editorial commentary: Free fall: Cardiometabolic disturbances, cancer and its treatment.

Editorial commentary: Free fall: Cardiometabolic disturbances, cancer and its treatment.

Journal: Trends in cardiovascular medicine

Published: November 18, 2025

Showing 1-12 of 288

Last Updated: 09/26/2026